Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/10/752
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
||
|
WHO-ATC |
A16AB10
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
||
|
NCI_THESAURUS |
C29726
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
||
|
EMA ASSESSMENT REPORTS |
VPRIV (AUTHORIZED: GAUCHER DISEASE)
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
||
|
WHO-VATC |
QA16AB10
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
||
|
NDF-RT |
N0000175820
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
||
|
FDA ORPHAN DRUG |
283509
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8925
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
VELAGLUCERASE ALFA
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
C87735
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
884604-91-5
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
DB06720
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
m11405
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | Merck Index | ||
|
23HYE36B0I
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL1201865
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
Velaglucerase alfa
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
23HYE36B0I
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
SUB31010
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
4989
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
901805
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000115858
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
7464
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY | |||
|
SS124
Created by
admin on Sat Dec 16 00:43:13 GMT 2023 , Edited by admin on Sat Dec 16 00:43:13 GMT 2023
|
PRIMARY |
ACTIVE MOIETY